RIMS2

RIMS2 is a presynaptic active zone scaffolding protein that functions as a Rab3A effector to regulate Ca²⁺-dependent exocytosis at both neuronal synapses and neuroendocrine secretory sites. Its N-terminal Rab-binding domain recognizes Rab3A through a critical acidic cluster (Glu-50/51/52), and its C2A domain adopts a Ca²⁺-independent β-sandwich fold with a dipolar electrostatic surface mediating protein–protein interactions (PMID:12578829, PMID:16216076). In pancreatic β-cells, RIMS2 forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex that mediates cAMP-dependent, PKA-independent insulin secretion potentiated by incretins, with Piccolo serving as the Ca²⁺ sensor (PMID:11598134, PMID:12401793). At neuronal synapses, RIMS2 redundantly controls presynaptic Ca²⁺ channel density and readily releasable pool size with RIM1, and at photoreceptor ribbon synapses it is stabilized by RIBEYE to organize CaV1.4 channel clusters; biallelic loss-of-function RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder with neurodevelopmental impairment and abnormal glucose homeostasis (PMID:25343783, PMID:32249787, PMID:32470375).

1. 2001 High

   The discovery that cAMP-GEFII (Epac2) partners with RIM2 to drive PKA-independent exocytosis in β-cells established the first signaling pathway through which RIM2 acts, revealing it as more than a structural scaffold — it is a functional node in incretin-potentiated insulin secretion.

   Evidence Antisense knockdown of cAMP-GEFII in pancreatic islets combined with PKA inhibition, reconstituted exocytosis system

   PMID:11598134

   Open questions at the time

   • Direct binding interface between Epac2 and RIM2 not mapped
   • Contribution of individual RIM2 domains to this pathway unknown
2. 2002 High

   Identification of the trimeric cAMP-GEFII·RIM2·Piccolo complex, with Piccolo as Ca²⁺ sensor, resolved how Ca²⁺ sensitivity is conferred on a cAMP-driven exocytotic pathway lacking direct Ca²⁺ binding by RIM2 itself.

   Evidence Co-immunoprecipitation, dimerization assays, antisense knockdown of Piccolo in pancreatic islets

   PMID:12401793

   Open questions at the time

   • Stoichiometry and assembly order of the tripartite complex undefined
   • Whether this complex operates at neuronal synapses unknown
3. 2003 High

   Systematic Rab-specificity mapping and mutagenesis of the RIM2 RBD identified Glu-50/51/52 as critical for Rab3A recognition and showed RIM2 differs from RIM1 in not binding Rab27A, establishing isoform-specific effector selectivity.

   Evidence Cotransfection binding assay with 42 Rab proteins, site-directed mutagenesis, chimeric analysis

   PMID:12578829

   Open questions at the time

   • No crystal structure of RIM2-RBD·Rab3A complex
   • Functional consequence of Rab8A interaction uncharacterized
4. 2005 High

   The 1.4 Å crystal structure of the RIM2 C2A domain revealed it does not bind Ca²⁺ and possesses a unique dipolar electrostatic surface, redefining it as a Ca²⁺-independent protein–protein interaction module rather than a classical Ca²⁺ sensor.

   Evidence X-ray crystallography, NMR spectroscopy, Ca²⁺-binding and protein-protein interaction assays

   PMID:16216076

   Open questions at the time

   • Physiological binding partners of the C2A bottom face not identified
   • Whether C2B domain similarly lacks Ca²⁺ binding untested
5. 2005 High

   Demonstrating that short RIM2-RBD isoforms are recruited to dense-core vesicles via Rab3A and promote regulated secretion, while long isoforms with reduced Rab3A affinity do not, linked Rab3A-binding capacity directly to vesicle targeting and exocytosis.

   Evidence In vitro binding, subcellular localization in PC12 cells, neuropeptide Y secretion assay with binding-defective mutant

   PMID:16473611

   Open questions at the time

   • Mechanism of long-form autoinhibition not structurally resolved
   • Whether isoform switching is physiologically regulated unknown
6. 2011 Medium

   Placing RIM2 within the GLP-1→cAMP→Epac2→RIM2→Rab3A cascade that enhances glucokinase activity extended its role beyond vesicle fusion to metabolic amplification of insulin secretion.

   Evidence RNAi knockdown of RIM2, Epac2, Rab3A in INS-1 and native β-cells with glucokinase activity and mitochondrial readouts

   PMID:22147008

   Open questions at the time

   • Mechanism by which vesicle-associated RIM2 regulates cytoplasmic glucokinase unclear
   • Single-lab finding not independently replicated
7. 2012 Medium

   Super-resolution imaging placed RIM2 inside the synaptic ribbon and CaV1.4 beneath it, and showed RIBEYE knockdown destabilizes RIM2, establishing the first spatial model of ribbon active zone architecture with RIM2 as an intermediary between RIBEYE and Ca²⁺ channels.

   Evidence STED microscopy and RIBEYE morpholino knockdown in zebrafish photoreceptors

   PMID:22832038

   Open questions at the time

   • Direct binding interface between RIBEYE and RIM2 not mapped
   • Whether this architecture is conserved across vertebrate ribbon synapses unknown
8. 2014 High

   Conditional double knockout of RIM1 and RIM2 at the calyx of Held quantitatively demonstrated their functional redundancy in maintaining presynaptic Ca²⁺ channel density and readily releasable pool size, establishing that neither isoform alone is essential at this synapse.

   Evidence Single and double conditional KO in mice with direct presynaptic patch-clamp electrophysiology at calyx of Held

   PMID:25343783

   Open questions at the time

   • Molecular mechanism of Ca²⁺ channel tethering by RIMs not resolved
   • Whether redundancy holds at smaller CNS boutons untested
9. 2020 Medium

   Convergent studies in RIBEYE KO mice and human patients with biallelic RIMS2 loss-of-function variants established that RIBEYE stabilizes RIM2/CaV1.4 at photoreceptor active zones and that RIMS2 loss causes congenital cone-rod synaptic disorder with neurodevelopmental and metabolic phenotypes, validating its essential role in vivo across tissues.

   Evidence RIBEYE KO mice with quantitative immunostaining; human genetic study with biallelic variants, RIMS2 localization in human retina/cerebellum/islets, insulin secretion assay with truncated RIMS2

   PMID:32249787 PMID:32470375

   Open questions at the time

   • Genotype–phenotype correlation across different RIMS2 variants limited
   • Whether partial loss-of-function alleles cause milder disease unknown
   • Rescue experiments not performed
10. 2024 Low

    RBM5 was identified as a trans-acting regulator of RIMS2 splicing and protein homeostasis, revealing a new upstream layer controlling RIMS2 isoform diversity in brain.

    Evidence Conditional RBM5 KO in mice with immunoprecipitation and western blot analysis of RIMS2 variants

    PMID:38218585

    Open questions at the time

    • Direct splicing mechanism and target exons not validated
    • Not independently confirmed
    • Functional consequence of the novel ~170 kDa RIMS2 variant unknown

• Key unresolved questions include the structural basis of RIM2 interactions with RIBEYE and Ca²⁺ channels, the mechanism by which the C2A domain's electrostatic surface recruits specific partners, and whether distinct RIMS2 splice variants serve non-redundant roles at different synapse types.
• No structure of RIM2 in complex with RIBEYE or CaV channels
• C2A physiological partners unidentified
• Isoform-specific functions at distinct synapse types not dissected